Back to my company list

Formation Bio

The AI engine Fit Assessment

Beta

Formation Bio effectively leverages machine learning and innovative technologies to expand therapeutic options and repurpose existing drugs, enhancing the drug development process.

Blurb

Formation Bio is a biotech company using AI to speed up drug development, aiming for efficient patient treatment.

HQ Location

United States

Founded

2013

Employees

51 - 200

Total funding raised

$528.00M

Last Funding Event

Series D, $372.00M, June 26, 2024

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
  • Drug Repurposing

Developer of a biotech platform designed to bring treatments to patients by re-imagining drug development. The company's platform has scaled a network of trial sites to create clinical trial sites within the existing practices using a roaming cohort of certified research coordinators, optimized by software, data, and technology, enabling researchers to expand their access to human subjects for research studies, paid clinical trials, psychological research, and focus groups.